0001564590-20-050481 | 10-Q | XBRL Viewer

^[1]

$ 85,332

$ 89,577

Cost of revenue:

General and administrative

^[2]

49,929

56,634

Gross profit

35,403

32,943

Operating expenses:

Research and development

12,148

13,341

Selling and marketing

8,898

13,266

8,889

10,616

Total operating expenses

29,935

37,223

Income (loss) from operations

5,468

(4,280)

Loss on equity method investment, net

(28)

Other expense, net

(4,694)

(4,439)

Income (loss) before provision for income taxes

746

(8,719)

Provision for income taxes

344

637

Net income (loss)

$ 402

$ (9,356)

Net income (loss) per share - basic

$ 0.00

$ (0.11)

Net income (loss) per share - diluted

$ 0.00

$ (0.11)

Weighted average common shares used in computing net income (loss) per share:

Basic

91,194

88,772

Diluted

91,681

88,772

Net income (loss)

$ 402

$ (9,356)

Foreign currency translation adjustment

1,493

(1,018)

Comprehensive income (loss)

1,895

(10,374)

Products

Net revenue:

31,258

37,605

Cost of revenue:

18,426

21,570

Services

Net revenue:

54,074

51,972

Cost of revenue:

$ 31,503

$ 35,064

[1]	Includes sales to the China joint venture, an equity method investment of $4,951 and $3,817 for three months ended September 30, 2020 and 2019, respectively. See Note 14.
[2]	Includes cost of revenue from sales to the China joint venture, an equity method investment of $1,944 and $2,491 for the three months ended September 30, 2020 and 2019, respectively. See Note 14.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical) - USD ($)
$ in Thousands

3 Months Ended

Sep. 30, 2020

Sep. 30, 2019

^[1]

$ 85,332

$ 89,577

Revenue from Joint Venture

^[2]

49,929

56,634

4,951

3,817

$ 1,944

$ 2,491

[1]	Includes sales to the China joint venture, an equity method investment of $4,951 and $3,817 for three months ended September 30, 2020 and 2019, respectively. See Note 14.
[2]	Includes cost of revenue from sales to the China joint venture, an equity method investment of $1,944 and $2,491 for the three months ended September 30, 2020 and 2019, respectively. See Note 14.

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income / (Loss)	Accumulated Deficit
Balance at Jun. 30, 2019	$ 49,871	$ 89	$ 535,332	$ (10)	$ (485,540)
Balance (in shares) at Jun. 30, 2019		88,521,511
Issuance of restricted stock	(207)		(207)
Issuance of restricted stock (in shares)		356,999
Share-based compensation	1,684		1,684
Net income (loss)	(9,356)				(9,356)
Cumulative translation adjustment	(1,018)			(1,018)
Balance at Sep. 30, 2019	40,974	$ 89	536,809	(1,028)	(494,896)
Balance (in shares) at Sep. 30, 2019		88,878,510
Balance at Jun. 30, 2020	$ 63,635	$ 91	545,741	(484)	(481,713)
Balance (in shares) at Jun. 30, 2020	91,178,108	91,178,108
Issuance of restricted stock (in shares)		95,575
Share-based compensation	$ 1,910		1,910
Net income (loss)	402				402
Cumulative translation adjustment	1,493			1,493
Balance at Sep. 30, 2020	$ 67,440	$ 91	$ 547,651	$ 1,009	$ (481,311)
Balance (in shares) at Sep. 30, 2020	91,273,683	91,273,683

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities
Net income (loss)	$ 402	$ (9,356)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	1,660	1,865
Share-based compensation	2,244	1,700
Amortization of debt issuance costs	357	329
Accretion of interest on debt	1,241	965
Change in (recovery of) allowance for doubtful accounts	(660)	22
Non-cash revenue transactions - Joint Venture	(1,365)
Provision for write-down of inventories	1,520	992
Loss on disposal of property and equipment	2
Loss on equity method investment	28
Deferral of equity method investment intra-entity profit on sales	(326)
Changes in assets and liabilities:
Accounts receivable	17,953	6,785
Inventories	(7,671)	(10,479)
Prepaid expenses and other assets	3,973	2,049
Deferred cost of revenue	(88)	(2)
Accounts payable	(5,202)	(5,704)
Operating lease liabilities, net	(157)	(82)
Accrued liabilities	(7,281)	(14,086)
Customer advances	(6,134)	(1,707)
Deferred revenues	(3,366)	2,088
Net cash used in operating activities	(2,870)	(24,621)
Cash flows from investing activities
Purchases of property and equipment	(569)	(1,267)
Net cash used in investing activities	(569)	(1,267)
Cash flows from financing activities
Taxes paid related to net share settlement of equity awards		(207)
Proceeds from debt, net of costs		24,716
Paydown on term loan	(10,000)
Loan amendment cost	(500)
Borrowings (repayments) under Revolving Credit Facility, net	(659)	2,941
Net cash (used in) provided by financing activities	(11,159)	27,450
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1,488	(1,852)
Net decrease in cash, cash equivalents and restricted cash	(13,110)	(290)
Cash, cash equivalents and restricted cash at beginning of period	109,911	88,178
Cash, cash equivalents and restricted cash at end of period	$ 96,801	$ 87,888

The Company and its Significant Accounting Policies

3 Months Ended

Sep. 30, 2020

The Company and its Significant Accounting Policies

Note 1. The Company and its Significant Accounting Policies

The Company

Accuray Incorporated (together with its subsidiaries, the “Company” or “Accuray”) designs, develops and sells advanced radiosurgery and radiation therapy systems for the treatment of tumors throughout the body. The Company is incorporated in Delaware and has its principal place of business in Sunnyvale, California. The Company has primary offices in the United States, Switzerland, China, Hong Kong and Japan and conducts its business worldwide.

Basis of Presentation

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant inter-company transactions and balances have been eliminated in consolidation.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”), pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair presentation of the periods presented. The results for the three months ended September 30, 2020 are not necessarily indicative of the results to be expected for the fiscal year ending June 30, 2021, or for any other future interim period or fiscal year.

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and accompanying notes for the fiscal year ended June 30, 2020 included in the Company’s Annual Report on Form 10-K filed with the SEC on August 25, 2020.

Risks and Uncertainties

The Company is subject to risks and uncertainties as a result of the coronavirus disease 2019 (“COVID-19”) pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict, as the effects of and response to the pandemic are rapidly evolving and new information is regularly coming to light. The Company's customers are diverting resources to treat COVID-19 patients and deferring non-urgent and elective procedures, both of which are likely to impact customers' ability to meet their other financial obligations, including to the Company. Some customers, which include hospitals, major academic medical centers, and other related entities, have incurred significant losses during the COVID-19 pandemic due to reduced patient volume. Furthermore, the Company is also anticipating a global economic slowdown due to disruptions caused by the COVID-19 pandemic, which may result in an incremental adverse impact on revenue, net income and cash flow and may require significant additional expenditures to mitigate such impacts. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and economy as a whole. The magnitude and overall effectiveness of these actions remain uncertain.

The Company’s financial results have also been affected by the COVID-19 pandemic in various ways. The COVID-19 pandemic is adversely impacting the pace at which the backlog converts to revenue in the near-term. This is primarily the result of delays in the timing of deliveries and installations in fiscal 2020 and into the first quarter of fiscal 2021 due to timing delays caused by the COVID-19 pandemic, which resulted in a decline in revenue for the same period. The Company expects that such delays in deliveries and installations will continue through fiscal 2021, which could continue to have a negative impact on revenue during such period. The Company has experienced disruptions in its sales and revenue cycle as well as increases in customer defaults, delays in payment and planned installations and service agreements as a result of the effect of the COVID-19 pandemic on the Company’s customers as well as restrictions imposed on travel. The Company also received requests from a few customers to extend payment terms or temporarily suspend service and corresponding payment obligations. While the Company has only received a small number of requests thus far, there can be no guarantee that more customers will not ask for the same if the effects of the COVID-19 pandemic deepen or worsen. As a result, the Company is carefully monitoring the pandemic and the resulting length and depth of the economic impact on our financial condition and results of operations. Given the uncertainty regarding the spread and resurgence of COVID-19 and how long the pandemic will last, the related financial impact cannot be reasonably estimated at this time, although the impacts are expected to continue and may also significantly affect the Company’s business.

The Company continues to critically review its liquidity and anticipated capital requirements in light of the significant uncertainty created by the COVID-19 pandemic. Based on the Company’s cash and cash equivalents balance, available debt facilities, current business plan and revenue prospects, the Company believes that it will have sufficient cash resources and anticipated cash flows to fund its operations for at least the next 12 months. However, the Company is unable to predict with certainty the impact of the COVID-19 pandemic on its ability to maintain compliance with the debt covenants contained in the credit and security agreements related to its

Revolving Credit Facility and Term Loan (as such terms are defined in Note 10 below), including financial covenants regarding the fixed charge coverage ratio, minimum net revenue, minimum consolidated cash balance and minimum consolidated domestic cash balance tests. The Company was in compliance with such covenants for the quarter ended September 30, 2020, as amended. Failure to meet the covenant requirements in the future could cause the Company to be in default and the maturity of the related debt could be accelerated and become immediately payable. This may require the Company to obtain waivers or amendments to the applicable credit and security agreement in order to maintain compliance and there can be no certainty that any such waiver or amendment will be available, or what the cost of such waiver or amendment, if obtained, would be. If the Company is unable to obtain necessary waivers or amendment and the debt under such credit facility is accelerated, the Company would be required to obtain replacement financing at prevailing market rates, which may not be favorable to the Company. There is no guarantee that the Company would be able to satisfy its obligations if any of its indebtedness is accelerated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures at the date of the financial statements. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of the COVID-19 pandemic. Key estimates and assumptions made by the Company relate to revenue recognition, assessment of recoverability of goodwill and intangible assets, valuation of our equity method investment in the JV, valuation of inventories, share based compensation expense, convertible notes, income taxes, allowance for doubtful accounts and loss contingencies. Actual results could differ materially from those estimates.

Significant Accounting Policies

Other than the policy adoption discussed below under Accounting Pronouncements Recently Adopted, there have been no changes in the Company’s significant accounting policies during the three months ended September 30, 2020 compared to the significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended June 30, 2020.

Recent Accounting Pronouncements

3 Months Ended

Sep. 30, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Recent Accounting Pronouncements

Note 2. Recent Accounting Pronouncements

Accounting Pronouncement Recently Adopted

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company adopted this update effective July 1, 2020 and the implementation of this update did not have a material impact on its consolidated financial position, results of operations or cash flows.

In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808) to clarify revenue accounting for collaborative arrangements entered into with customers. The Company adopted this standard effective July 1, 2020. The adoption of this standard had no impact on our condensed consolidated financial statements and disclosure.

Accounting Pronouncements Not Yet Effective

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying Accounting for Income Taxes (“ASU 2019-12”). The amendments in ASU 2019-12 are intended to simplify various aspects related to accounting for income taxes and reduce the cost of accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for the Company beginning July 1, 2021 with early adoption permitted. The Company is evaluating the impact of adopting this standard to its consolidated financial statements and related disclosures.

In January 2020, the FASB issued ASU 2020-01 Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This guidance addresses accounting for the transition into and out of the equity method and provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2020-01, which is effective for the Company in its fiscal year and interim periods beginning on July 1, 2021, to its consolidated financial statements and related disclosures.

In March 2020, the FASB issued an update (“ASU 2020-04”) establishing Accounting Standards Codification (“ASC”) Topic 848, Reference Rate Reform. ASU 2020-04 contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU 2020-04 is optional and may be elected over time as reference rate reform activities occur. The Company is currently evaluating the impact of the guidance and our options related to the practical expedients.

Revenue

3 Months Ended

Sep. 30, 2020

Revenue From Contract With Customer [Abstract]

Revenue

Note 3. Revenue

Contract Balances

The Company offers payment terms of more than one year for qualified customers and transactions in rare circumstances. At times, revenue recognition occurs before billing, resulting in an unbilled receivable, which represents a contract asset. The contract asset is a component of accounts receivable and other assets for the current and non-current portions, respectively.

Customer advances represent deposits from customers for shipments of systems. Deferred revenue balances represent active and non-active warranties and services, which are recognized based on contract terms. When the Company receives advances or deposits from customers before revenue is recognized, this results in a contract liability. It can take up to two and half years from the time of order to revenue recognition due to the Company’s long sales cycle.

Changes in the contract assets and contract liabilities are as follows:

	September 30, 2020		June 30, 2020
(Dollars in thousands)	Amount		Amount
Contract Assets:
Unbilled accounts receivable – current (1)	$	12,093	$	11,739
Interest receivable – current (2)		583		493
Long-term accounts receivable (3)		3,429		3,810
Interest receivable – non-current (3)		1,286		1,342
Contract Liabilities:
Customer advances		16,712		22,571
Deferred revenue – current		81,344		83,207
Deferred revenue – non-current		24,406		24,125

(1)	Included in accounts receivable on the Company’s consolidated balance sheet

(2)	Included in prepaid expenses and other current assets on the Company’s consolidated balance sheet

(3)	Included in other assets on the Company’s consolidated balance sheet

During the quarter ended September 30, 2020, contract assets changed primarily due changes in the timing of billings that occurred after revenues were recognized and changes in transactions with payment terms exceeding 12 months. Contract liabilities changed due to changes in the timing of recognition of revenue for system sales for which the warranty has not yet started and was deferred and due to changes in transaction price.

During the three months ended September 30, 2020 and 2019, the Company recognized revenues of $8.8 million, and $11.2 million, respectively, which were included in the deferred revenue balances at June 30, 2020 and 2019, respectively.

Remaining Performance Obligations

Remaining performance obligations represent deferred revenue from open contracts for which performance has already started and the transaction price from executed and non-cancellable contracts for which performance has not yet started. Service contracts in general are considered month-to-month contracts, and therefore, the Company has elected the practical expedient to not disclose the value of unsatisfied performance obligations for contracts with an original expected duration of one year or less.

As of September 30, 2020, total remaining performance obligations amounted to $984.9 million. Of this total amount, $78.7 million related to long-term warranty and service, which is expected to be recognized over the remaining warranty period for systems that have been delivered. For systems that have been delivered but not yet installed, management estimates the timing of installation since warranty starts upon installation.

The following table represents the Company's remaining performance obligations related to long-term warranty and service as of September 30, 2020 and the estimated revenue expected to be recognized:

	Fiscal years of revenue recognition
(Dollars in thousands)	2021		2022		2023		Thereafter
Long-term warranty and service	$	29,526	$	25,530	$	13,054	$	10,550

For the remaining $906.2 million of performance obligations, the Company estimates 21% to 28% will be recognized in the next 12 months, and the remaining portion will be recognized in the 30 months thereafter. The Company’s historical experience indicates that some of its customers will cancel or renegotiate contracts as economic conditions change or when product offerings change during the long sales cycle. Based on historical cancellations, approximately 23% of the Company’s contracts may never result in revenue due to cancellation.

The time bands reflect management’s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers’ facilities for installation, installation requirements, and availability of products.

Capitalized Contract Costs

The Company capitalizes and amortizes the incremental costs of obtaining a contract, primarily related to certain bonuses and sales commissions. The capitalized bonuses and sales commissions are amortized over a period of five years commencing upon the initial transfer of control of the system to the customer following the pattern of transfer of control of the performance obligations to the customer.

The balance of capitalized costs to obtain a contract was $7.4 million and $7.9 million as of September 30, 2020 and June 30, 2020, respectively. The Company has classified the capitalized costs to obtain a contract as a component of prepaid expenses and other current assets and other assets with respect to the current and non-current portions of capitalized costs, respectively, on the consolidated balance sheets. During the three months period ended September 30, 2020 and 2019, the Company recognized $0.7 million and $0.5 million, respectively in expense related to the amortization of the capitalized contract costs. Included in the amortization expense, the Company booked $0.1 million in impairment loss for each of the three month period ended September 30, 2020 and 2019, respectively.

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Supplemental Financial Information Disclosure [Abstract]

Supplemental Financial Information

3 Months Ended

Sep. 30, 2020

Supplemental Financial Information

Note 4. Supplemental Financial Information

Balance Sheet Components

Financing receivables

A financing receivable is a contractual right to receive money, on demand or on fixed or determinable dates, that is recognized as an asset in the Company’s balance sheet. The Company’s financing receivables, consisting of its accounts receivable with contractual maturities of more than one year, totaled $3.5 million and $3.8 million at September 30, 2020 and June 30, 2020, respectively, and are included in Other Assets in the unaudited condensed consolidated balance sheet. The Company evaluates the credit quality of an obligor at contract inception and monitors credit quality over the term of the underlying transactions. The Company performs a credit analysis for all new customers and reviews payment history, current order backlog, financial performance of the customers and other variables that augment or mitigate the inherent credit risk of a particular transaction. Such variables include the underlying value and liquidity of the collateral, the essential use of the equipment, the contract term and the inclusion of credit enhancements, such as guarantees, letters of credit or security deposits. The Company classifies accounts as high risk when it considers the financing receivable to be impaired or when management believes there is a significant near-term risk of non-payment. The Company performed an assessment of the allowance for credit losses and impairments related to its financing receivables as of September 30, 2020 and June 30, 2020. Based upon such assessment, the Company recorded an allowance for credit losses related to such financing receivables of $4.4 million at each of the periods ended September 30, 2020 and June 30, 2020, respectively.

A summary of the Company’s financing receivables is presented as follows (in thousands):

	September 30, 2020			June 30, 2020
Gross	$	13,042		$	13,019
Residual value		—			—
Unearned income		(1,805	)		(1,774	)
Allowance for credit loss		(4,380	)		(4,369	)
Total, net	$	6,857		$	6,876
Reported as:
Current	$	3,337		$	3,084
Non-current		3,520			3,792
Total, net	$	6,857		$	6,876

Inventories, net

Inventories, net consisted of the following (in thousands):

	September 30, 2020		June 30, 2020
Raw materials	$	57,168	$	48,037
Work-in-process		17,722		17,798
Finished goods		66,127		68,539
Inventories, net	$	141,017	$	134,374

Property and equipment, net

Property and equipment, net consisted of the following (in thousands):

	September 30, 2020			June 30, 2020
Furniture and fixtures	$	1,869		$	1,961
Computer and office equipment		10,486			10,896
Software		11,493			11,606
Leasehold improvements		26,082			26,206
Machinery and equipment		48,524			48,830
Construction in progress		800			623
		99,254			100,122
Less: Accumulated depreciation		(84,714	)		(84,773	)
Property and equipment, net	$	14,540		$	15,349

Depreciation expense related to property and equipment for the three months ended September 30, 2020 and 2019 was $1.6 million and $1.8 million, respectively.

Accumulated Other Comprehensive Income (Loss)

The changes in accumulated other comprehensive income (loss) are excluded from earnings and reported as a component of stockholders’ equity. The foreign currency translation adjustment results from those subsidiaries not using the U.S. Dollar as their functional currency since the majority of their economic activities are primarily denominated in their applicable local currency. Accordingly, all assets and liabilities related to these operations are translated to the U.S. Dollar at the current exchange rates at the end of each period. Revenues and expenses are translated at average exchange rates in effect during the period.

The components of accumulated other comprehensive income (loss) in the equity section of the Company’s condensed consolidated balance sheet are as follows (in thousands):

	September 30, 2020			June 30, 2020
Cumulative foreign currency translation adjustment	$	2,240		$	752
Defined benefit pension obligation		(1,231	)		(1,236	)
Accumulated other comprehensive income (loss)	$	1,009		$	(484	)

Leases

3 Months Ended

Sep. 30, 2020

Leases [Abstract]

Leases

Note 5. Leases

The Company has operating leases for corporate offices and warehouse facilities worldwide. Additionally, the Company leases cars, copy machines and laptops through various operating leases. For some leases the Company has entered into non-cancelable operating lease agreements with various expiration dates through June 2025. Certain lease agreements include options to renew or terminate the lease, which are not reasonably certain to be exercised and therefore are not factored into the determination of lease payments.

Operating lease costs for the three months ended September 30, 2020 were $2.4 million not including $0.1 million short-term operating lease costs.

For the three months ended September 30, 2020, cash paid for amounts included in the measurement of operating lease liabilities was approximately $2.4 million. Operating lease liabilities arising from obtaining operating right-of-use assets totaled $0.2 million for the three months ended September 30, 2020.

Maturities of operating lease liabilities as of September 30, 2020 are presented in the table below (in thousands):

Year Ending June 30,	Amount
2021 (remaining 9 months)	$	7,171
2022		9,311
2023		8,676
2024		5,922
2025		3,032
Thereafter		—
Total operating lease payments		34,112
Less: imputed interest		(3,136	)
Present value of operating lease liabilities	$	30,976
Weighted average remaining lease term (in years)		3.88
Weighted average discount rate		5.28	%

Goodwill and Intangible Assets

3 Months Ended

Sep. 30, 2020

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Note 6. Goodwill and Intangible Assets

Goodwill

Activity related to goodwill consisted of the following (in thousands):

	September 30, 2020		June 30, 2020
Balance at the beginning of the period	$	57,717	$	57,770
Currency translation		117		(53	)
Balance at the end of the period	$	57,834	$	57,717

In fiscal 2020, the Company performed its annual goodwill impairment test and determined that there was no impairment to goodwill. In addition, during the first quarter of fiscal year 2021, the Company reviewed for possible triggering events due to circumstances surrounding the COVID-19 pandemic and no impairment loss was recorded as a result of such review. The Company will continue to monitor its recorded goodwill for indicators of impairment.

Intangible Assets

The Company’s carrying amount of acquired intangible assets, net, is as follows (in thousands):

		September 30, 2020							June 30, 2020
	Useful Lives	Gross Carrying Amount		Accumulated Amortization			Net Amount		Gross Carrying Amount		Accumulated Amortization			Net Amount
	(in years)
Patent license	2 - 7	$	1,170	$	(564	)	$	606	$	1,170	$	(507	)	$	663

During fiscal 2017, the Company purchased a patent license with a useful life of seven years. During the quarter ending March 31, 2020, the Company purchased a patent license for $170 thousand with a useful life of two years. The Company did not identify any triggering events that would indicate potential impairment of its definite-lived intangible and long-lived assets as of September 30, 2020 and June 30, 2020.

Amortization expense related to intangible assets for the three months ended September 30, 2020 and 2019 was $0.06 million and $0.04 million, respectively.

The estimated future amortization expense of acquired intangible assets as of September 30, 2020 is as follows (in thousands):

Year Ending June 30,	Amount
2021 (remaining 9 months)	$	171
2022		185
2023		143
2024		107
	$	606

Derivative Financial Instruments

3 Months Ended

Sep. 30, 2020

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Note 7. Derivative Financial Instruments

The Company manages some of its foreign currency risk through the purchase of foreign currency forward contracts that hedge against the short-term effect of currency fluctuations. These foreign currency forward contracts have a monthly maturity that mitigates the effect of rate fluctuations on certain local currency denominated intercompany balances, cash, and customer receivables. The Company does not use derivative financial instruments for speculative or trading purposes. These forward contracts are not designated as hedging instruments for accounting purposes. Principal hedged currencies include the Euro, Japanese Yen, Swiss Franc, and U.S. Dollar. There were no outstanding foreign currency forward contracts at the end of September 30, 2020 and June 30, 2020.

The following table provides information about gain (loss) associated with the Company’s derivative financial instruments (in thousands):

	Three Months Ended September 30,			Three Months Ended September 30,
	2020			2019
Foreign currency exchange gain (loss) on foreign contracts	$	(910	)	$	118
Foreign currency transactions gain (loss)		404			(538	)

Fair Value Measurements

3 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 8. Fair Value Measurements

Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, as follows:

Level 1— Unadjusted quoted prices that are available in active markets for the identical assets or liabilities at the measurement date.

Level 2— Other observable inputs available at the measurement date, other than quoted prices included in Level 1, either directly or indirectly, including:

•

Quoted prices for similar assets or liabilities in active markets;

•

Quoted prices for identical or similar assets in non-active markets;

•

Inputs other than quoted prices that are observable for the asset or liability; and

•

Inputs that are derived principally from or corroborated by other observable market data.

Level 3— Unobservable inputs that cannot be corroborated by observable market data and require the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions.

The Company had a cash balance of $90.0 million and $107.6 million at September 30, 2020 and June 30, 2020, respectively.

Assets and Liabilities That Are Measured at Fair Value on a Nonrecurring Basis

The Company’s debt is measured on a non-recurring basis using Level 2 inputs based upon observable inputs of the Company’s underlying stock price and the time value of the conversion option since an observable quoted price of the 3.75% Convertible Notes (as defined below) is not readily available. The Revolving Credit Facility (as defined below) and the Term Loan (as defined below) (collectively, the “Credit Facilities”) are valued at market interest rates, which the Company considers to be a Level 2 fair value measurement. The Company believes that the carrying value of these financial instruments approximate its estimated fair value based on the effective interest rate compared to the current market rate available to the Company.

The following table summarizes the carrying value and estimated fair value of the Credit Facilities and the 3.75% Convertible Notes (in thousands):

	September 30, 2020				June 30, 2020
	Carrying Value		Fair Value		Carrying Value		Fair Value
3.75% Convertible Notes	$	77,374	$	73,746	$	76,398	$	65,272
Term Loan Facility		74,972		74,972		84,908		84,908
Revolving Credit Facility		27,343		27,343		28,001		28,001
Total	$	179,689	$	176,061	$	189,307	$	178,181

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

3 Months Ended

Sep. 30, 2020

Commitments and Contingencies

Note 9. Commitments and Contingencies

Litigation

From time to time, the Company is involved in legal proceedings arising in the ordinary course of its business. The Company records a provision for a loss when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. To the extent there is a reasonable possibility that a loss exceeding amounts already recognized may be incurred and the amount of such additional loss would be material, we will either disclose the estimated additional loss or state that such an estimate cannot be made. Currently, management believes the Company does not have any probable and reasonably estimable material losses related to any current legal proceedings and claims. Although occasional adverse decisions or settlements may occur, management does not believe that an adverse determination with respect to any of these claims would individually or in the aggregate materially and adversely affect the Company’s financial condition or operating results. Litigation is inherently unpredictable and is subject to significant uncertainties, some of which are beyond the Company’s control. Should any of these estimates and assumptions change or prove to have been incorrect, the Company could incur significant charges related to legal matters that could have a material impact on its results of operations, financial position and cash flows.

Indemnities

Under the terms of the Company’s software license agreements with its customers, the Company agrees that in the event the software sold infringes upon any patent, copyright, trademark, or any other proprietary right of a third‑party, it will indemnify its customer licensees against any loss, expense, or liability from any damages that may be awarded against its customer. The Company includes this infringement indemnification in all of its software license agreements and selected managed services arrangements. In the event the customer cannot use the software or service due to infringement and the Company cannot obtain the right to use, replace or modify the license or service in a commercially feasible manner so that it no longer infringes, then the Company may terminate the license and provide the customer a refund of the fees paid by the customer for the infringing license or service. The Company has not recorded any liability associated with this indemnification, as it is not aware of any pending or threatened actions that represent probable losses as of September 30, 2020.

The Company enters into standard indemnification agreements with its landlords and all superior mortgagees and their respective directors, officers’ agents, and employees in the ordinary course of business. Pursuant to these agreements, the Company will indemnify, hold harmless, and agree to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally the landlords, in connection with any loss, accident, injury, or damage by any third‑party with respect to the leased facilities. The term of these indemnification agreements is from the commencement of the lease agreements until termination of the lease agreements. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, historically, the Company has not incurred claims or costs to defend lawsuits or settle claims related to these indemnification agreements. The Company has not recorded any liability associated with its indemnification agreements as it is not aware of any pending or threatened actions that represent probable losses as of September 30, 2020.

Guarantees

As of September 30, 2020 and June 30, 2020, the Company had various bank guarantees totaling approximately $1.3 million and $1.0 million, respectively, related to bidding processes with customers.

Debt

3 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Debt

Note 10. Debt

3.75% Convertible Senior Notes due July 2022

In August 2017, the Company issued $85.0 million aggregate principal amount of its 3.75% Convertible Senior Notes due 2022 (the “3.75% Convertible Notes”) under an indenture between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee.

Holders of the 3.75% Convertible Notes may convert their notes at any time on or after April 15, 2022 until the close of the business day immediately preceding the maturity date. Prior to April 15, 2022, holders of the 3.75% Convertible Notes may convert their notes only under certain circumstances.

Upon conversion, the Company will have the right to pay cash, or deliver shares of common stock of the Company or a combination thereof, at the Company’s election. The initial conversion rate is 174.8252 shares of the Company’s common stock per $1,000 principal amount (which represents an initial conversion price of approximately $5.72 per share of the Company’s common stock). The conversion rate, and thus the conversion price, is subject to adjustment as further described below.

Holders of the 3.75% Convertible Notes who convert their notes in connection with a “make-whole fundamental change,” as defined in the indenture, may be entitled to a make-whole premium in the form of an increase in the conversion rate. Additionally, in the event of a “fundamental change,” as defined in the indenture, holders of the 3.75% Convertible Notes may require the Company to purchase all or a portion of their note at a fundamental change repurchase price equal to 100% of the principal amount of the 3.75% Convertible Notes, plus accrued and unpaid interest, if any, to, but not including, the fundamental change repurchase date. As of September 30, 2020, $85.0 million of aggregate principal amount was outstanding.

Revolving Credit Facility

On June 14, 2017, the Company entered into a credit and security agreement with a lender (the “Credit Agreement”). The Credit Agreement provides the Company with a revolving credit facility in the initial amount of $52.0 million (the “Revolving Credit Facility”). Availability for borrowings under the Revolving Credit Facility is subject to a borrowing base that is calculated as a function of the value of the Company’s eligible accounts receivable and eligible inventory, and the Company is required to maintain a minimum drawn balance of at least 30% of such availability. Interest on the borrowings under the Revolving Credit Facility is payable monthly in arrears at an annual interest rate of reserve-adjusted, 90-day LIBOR plus 4.50% and had an initial maturity date of June 14, 2021.

In December 2017, concurrently with the Term Loan Agreement described below, the Company entered into an amendment to the Credit Agreement (the “Amendment” and, collectively with the Credit Agreement, the “Amended Credit Agreement”). The Amendment reduced the maximum borrowings under the Revolving Credit Facility to $32.0 million and extended the maturity date of the Revolving Credit Facility to December 15, 2022.

In May 2019, the Company amended the Amended Credit Agreement to, among other things, decrease the interest rate from 90-day LIBOR plus 4.50% to 90-day LIBOR plus 3.50% and extend the maturity date to May 30, 2024 and update the calculation of the deferred revolving loan origination fee such that it is based on the amount of time elapsed from the effective date of the May 2019 amendment. The Company accounted for the amendment as a modification of existing debt and deferred an insignificant amount of offering costs on its consolidated balance sheet. The Amended Credit Agreement was further amended in August 2019 to, among other things, revise or add financial covenants, including the fixed charge coverage ratio, minimum net revenue, minimum consolidated cash balance and minimum consolidated domestic cash balance tests. Other significant terms remain unchanged. The Company accounted for the amendment as a modification of existing debt and deferred an insignificant amount of offering costs on its consolidated balance sheet.

In July 2020, the Company further amended the Amended Credit Agreement to which, among other things modified certain financial covenants related to the Fixed Charge Coverage Ratio, minimum consolidated Net Revenue and minimum consolidated cash balance. Other significant terms remain unchanged. The Company accounted for the amendment as a modification of existing debt and deferred an insignificant amount of offering costs on its consolidated balance sheet.

The Company was in compliance with the covenants under the Amended Credit Agreement, as amended, as of September 30, 2020. As of September 30, 2020, approximately $27.3 million of aggregate principal amount was outstanding under the Revolving Credit Facility.

Term Loan

In December 2017, the Company entered into a credit and security agreement with a lender (the “Term Loan Agreement”). The Term Loan Agreement provides for an initial term loan of $40.0 million with an additional tranche of $20.0 million undrawn and available through December 31, 2018, if specified conditions are met (the “Term Loan”). In connection with the Amendment, the Company used a portion of the net proceeds from the initial advance to repay a portion of the outstanding borrowings under the Revolving Credit Facility. Interest on the Term Loan is payable monthly in arrears at an annual interest rate of 6.75% plus 90-day LIBOR. The Term Loan Agreement matures December 15, 2022 and, if prepaid, has fees equal to 3%, 2%, and 1% of the prepayment amount if such termination occurs within the first year, the second year, and the third year of funding, respectively. The term of the Term Loan is 60 months with interest only for the first 24 months followed by straight-line amortization of principal for the remaining months. In addition, the Company pays an annual administrative fee of 0.25% and is required to make a final payment of 4.0% of the Term Loan amount.

In December 2018, the Company drew an additional $5.0 million under the Term Loan Agreement and in connection therewith amended the Term Loan Agreement to, among other things, (i) extended the term loan second tranche commitment termination date for the remaining $15.0 million unfunded commitment from December 31, 2018 to June 30, 2019; (ii) provided that term loan second tranche may be drawn in two separate advances; and (iii) updated the calculation of the prepayment fee such that it is based on the amount of time elapsed from the effective date of the December 2018 amendment.

In May 2019, the Company amended the Term Loan Agreement to, among other things, increase the loan second tranche commitment by $0.5 million, extend the maturity date to May 30, 2024, decrease the annual interest rate from 6.75% plus 90-day LIBOR to 5.50% plus 90-day LIBOR, and modify the calculation of the prepayment fee such that it is based on the amount of time elapsed from the effective date of the May 2019 amendment. The Company accounted for the amendment as a modification of existing debt and recorded approximately $1.5 million of debt discount costs associated with the amendment against long-term debt on the consolidated balance sheets.

In August 2019, the Company amended the Term Loan Agreement to, among other things, increase the loan commitment by $25 million in the form of a new tranche (“Tranche 3”), increase the annual interest rate from 5.50% plus 90-day LIBOR to 6.75% plus 90-day LIBOR, and revise or add financial covenants, including the fixed charge coverage ratio, minimum net revenue, minimum consolidated cash balance and minimum consolidated domestic cash balance tests. Other significant terms remain unchanged. The Company borrowed in full Tranche 3, or $25 million, on the date of the amendment. The Company accounted for the amendment as a modification of existing debt, at the same time, the Company recorded approximately $1.6 million of debt discount costs associated with the amendment against long-term debt.

In July 2020, the Company further amended the Term Loan Agreement which, among other things modified certain financial covenants related to the Fixed Charge Coverage Ratio, minimum consolidated Net Revenue and minimum consolidated cash balance. Other significant terms remained unchanged. In addition, the Company agreed to prepay $10.0 million in principal with respect to the Term Loan. The Company accounted for the amendment as a modification of existing debt and, at the same time, the Company recorded approximately $0.5 million of debt amendment fee associated with the amendment.

As of September 30, 2020, approximately $79.9 million aggregate principal amount of the Term Loan was outstanding.

The following table presents the carrying value of the Revolving Credit Facility, the 3.75% Convertible Notes, and the Term Loan (together, the “Notes”) (in thousands):

As of September 30, 2020	Revolving Credit Facility (1)		3.75% Convertible Notes			Term Loan Facility			Total
Carrying amount of equity conversion component	$	—	$	14,650		$	—		$	14,650
Principal amount of the Notes	$	27,343	$	85,000		$	79,948		$	192,291
Unamortized debt costs		—		(1,713	)		(785	)		(2,498	)
Unamortized debt discount		—		(5,913	)		(4,191	)		(10,104	)
Net carrying amount	$	27,343	$	77,374		$	74,972		$	179,689
Reported as:
Short-term debt									$	6,162
Long-term debt										173,527
Total debt									$	179,689

(1)	Unamortized debt costs of $0.8 million recorded in other assets on the consolidated balance sheet.

June 30, 2020	Revolving Credit Facility		3.75% Convertible Notes			Term Loan Facility			Total
Carrying amount of equity conversion component	$	—	$	14,650		$	—		$	14,650
Principal amount of the Notes	$	28,001	$	85,000		$	89,093		$	202,094
Unamortized debt costs		—		(1,922	)		(874	)		(2,796	)
Unamortized debt discount		—		(6,680	)		(3,311	)		(9,991	)
Net carrying amount	$	28,001	$	76,398		$	84,908		$	189,307
Reported as:
Short-term debt									$	—
Long-term debt										189,307
Total debt									$	189,307

A summary of interest expense on the Notes and Credit Facilities is as follows (in thousands):

	Three Months Ended September 30,
	2020		2019
Interest expense related to contractual interest coupon	$	2,785	$	2,862
Interest expense related to amortization of debt discount		1,241		965
Interest expense related to amortization of debt issuance costs		357		329
	$	4,383	$	4,156

Share-Based Compensation

3 Months Ended

Sep. 30, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Share-Based Compensation

Note 11. Share-Based Compensation

The following table presents details of share-based compensation expenses by functional line item (in thousands):

	Three Months Ended September 30,
	2020		2019
Cost of revenue	$	261	$	374
Research and development		407		372
Selling and marketing		339		(24	)
General and administrative		1,237		978
	$	2,244	$	1,700

Net Income (Loss) Per Common Share

3 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Net Income (Loss) Per Common Share

Note 12. Net Income (Loss) Per Common Share

The Company reports both basic and diluted loss per share, which is based on the weighted average number of common shares outstanding during the period.

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per common share follows (in thousands):

	Three Months Ended September 30,
	2020		2019
Numerator:
Net income (loss)	$	402	$	(9,356	)
Denominator:
Weighted average shares outstanding - basic		91,194		88,772
Dilutive effect of potential common shares		487		—
Weighted average shares outstanding - diluted		91,681		88,772
Basic net income (loss) per share	$	0.00	$	(0.11	)
Diluted net income (loss) per share	$	0.00	$	(0.11	)

The potentially dilutive shares of the Company’s common stock resulting from the assumed exercise of outstanding stock options; the vesting of Restricted Stock Units (RSUs), Market Stock Units (MSUs) and Performance Stock Units (PSUs), and the purchase of shares under the Employee Stock Purchase Program (ESPP), as determined under the treasury stock method, are included in the calculation of diluted net income per share only if their inclusion is dilutive. Additionally, the 3.75% Convertible Notes are included in the calculation of diluted net income per share only if their inclusion is dilutive for periods during which the notes were outstanding.

The following table sets forth all potentially dilutive securities excluded from the computation in the table above because their effect would have been anti-dilutive (in thousands):

	As of September 30,
	2020		2019
Stock options		5,913		4,772
RSUs, PSUs and MSUs		3,092		3,083
		9,005		7,855

3.75% Convertible Notes—Diluted Share Impact

The 3.75% Convertible Notes have an optional physical (share), cash or combination settlement feature and contain certain conditional conversion features. Due to the optional cash settlement feature and management’s intent to settle the principal amount thereof in cash, the shares of our common stock issuable upon conversion of the outstanding principal amount of the 3.75% Convertible Notes as of September 30, 2020, totaling approximately 14.9 million shares of our common stock, were not included in the basic and diluted net loss per common share table above.

Segment Information

3 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Segment Information

Note 13. Segment Information

The Company has one operating and reporting segment (oncology systems group), which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients. The Company’s Chief Executive Officer, its Chief Operating Decision Maker, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Company does not assess the performance of its individual product lines on measures of profit or loss, or asset-based metrics. Therefore, the information below is presented only for revenues and long-lived tangible assets by geographic area.

Disaggregation of Revenues

The Company disaggregates its revenues from contracts by geographic region, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. Additionally, the Company typically recognizes revenue at a point in time for product revenue and recognizes revenue over time for service revenue.

Revenues attributed to a country or region is based on the shipping addresses of the Company’s customers. The following summarizes revenue by geographic region (in thousands):

	Three Months Ended September 30,
	2020		2019
Americas	$	29,388	$	29,429
Europe, Middle East, India and Africa		28,583		31,600
Asia Pacific		15,208		14,067
Japan		12,153		14,481
Total	$	85,332	$	89,577

Information regarding geographic areas in which the Company has long-lived tangible assets is as follows (in thousands):

	September 30,		June 30,
	2020		2020
Americas	$	12,200	$	12,807
Europe, Middle East, India and Africa		367		373
Asia Pacific		885		986
Japan		1,088		1,183
Total	$	14,540	$	15,349

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

Equity Method Investments And Joint Ventures [Abstract]

Joint Venture

3 Months Ended

Sep. 30, 2020

Joint Venture

Note 14. Joint Venture

In January 2019, the Company’s wholly-owned subsidiary, Accuray Asia Limited (“Accuray Asia”), entered into an agreement with CNNC High Energy Equipment (Tianjin) Co., Ltd. (the “CIRC Subsidiary”), a wholly-owned subsidiary of China Isotope & Radiation Corporation, to form a joint venture, CNNC Accuray (Tianjin) Medical Technology Co. Ltd. (the “JV”), to manufacture and sell radiation oncology systems in China.

In exchange for a 49% equity interest in the JV, the Company, through Accuray Asia, made in-kind capital contributions of two full radiation oncology systems from the Company’s inventory in the quarter ended December 31, 2019 and one system upgrade, which was not to be sold and only be used for training purposes, in the quarter ended September 30, 2020. The investments are reported as an Investment in joint venture on the Company’s consolidated balance sheets. During the quarter ended December 31, 2019, the Company recognized non-operating gain of $13.0 million related to the value of the capital contribution made during the quarter ended December 31, 2019 to the JV, which was recorded in other income. During the quarter ended September 30, 2020, the Company recognized non-cash revenue of $1.4 million with corresponding associated costs of $0.2 million recorded to costs of revenue related to the value of the capital contribution made during the quarter ended September 30, 2020.

The Company applies the equity method of accounting to its ownership interest in the JV as the Company has the ability to exercise significant influence over the JV but lacks controlling financial interest and is not the primary beneficiary. The Company recognizes revenue on sales to the JV in the current period, eliminating a portion of profit to the extent goods sold have not been sold through by the JV to an end customer at the end of such reporting period. The Company deferred $1.5 million and $1.8 million of intra-entity profit margin as of September 30, 2020 and June 30, 2020, respectively. During the three months ended September 30, 2020, the Company recognized $1.0 million of previously deferred intra-entity profit margin from system sales and recorded intra-entity profit margin deferral of $0.7 million from system sales executed during the period. The Company’s consolidated accumulated deficit includes $0.2 million of accumulated losses related to our equity method investment.

As of September 30, 2020, the Company had a carrying value of $15.6 million in the JV and owned a 49% interest in the entity. The Company’s proportional share of the underlying equity in net assets of the JV was approximately $12.3 million. The difference represents equity method goodwill. The carrying value of the Company’s investment in the JV was decreased by $1.5 million during the quarter ended September 30, 2020 as result of intra-entity profit that was not considered in the goodwill assessment. The difference between the carrying value of the JV and value of its underlying equity in net assets of the JV of $3.3 million increased by the $1.5 million of eliminated profit constitutes equity method goodwill of $4.8 million, which is subject to impairment analysis. No impairment was identified as of September 30, 2020.

Income Tax

3 Months Ended

Sep. 30, 2020

Income Tax Disclosure [Abstract]

Income Tax

Note 15. Income Tax

On a quarterly basis, the Company provides for income taxes based upon an estimated annual effective income tax rate. The Company recognized income tax expense of $0.3 million and $0.6 million for the three months ended September 30, 2020 and 2019, respectively, primarily related to foreign taxes.

Starting in fiscal year 2019, certain income earned by controlling foreign corporations (“CFCs”) must be included in the gross income of the CFC’s U.S. shareholder. The income required to be included in gross income is referred to as global intangible low tax income (“GILTI”) and is defined under IRC Section 951A as the excess of the shareholder’s net CFC tested income over the net deemed tangible income return. The GILTI inclusion amount is expected to be fully absorbed by net operating losses carryforward and is not expected to cause the Company to be in a U.S. taxable income position for fiscal year 2021.

In addition to the GILTI provision, the Tax Act also enacted the Base Erosion and Anti-Abuse Tax (“BEAT”). The BEAT minimum tax under IRC Section 59A is applicable to the extent that the BEAT tax amount is greater than the regular corporate tax for a given year. This tax is applicable to companies with prior 3-year average annual gross receipts exceeding $500 million. The Company does not currently meet this threshold since its current average annual gross receipts are less than $500 million.

The Company does not expect its gross unrecognized tax benefits of $17.0 million to change significantly over the next 12 months. In addition, these unrecognized tax benefits would not affect the Company’s income tax expense before consideration of any valuation allowance. Interest and penalties accrued on unrecognized tax benefits is recorded as a component of income tax expense.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

Revenue From Contract With Customer [Abstract]

The Company and its Significant Accounting Policies (Policies)	3 Months Ended
	Sep. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant inter-company transactions and balances have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”), pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair presentation of the periods presented. The results for the three months ended September 30, 2020 are not necessarily indicative of the results to be expected for the fiscal year ending June 30, 2021, or for any other future interim period or fiscal year. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and accompanying notes for the fiscal year ended June 30, 2020 included in the Company’s Annual Report on Form 10-K filed with the SEC on August 25, 2020.
Risks and Uncertainties	Risks and Uncertainties The Company is subject to risks and uncertainties as a result of the coronavirus disease 2019 (“COVID-19”) pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict, as the effects of and response to the pandemic are rapidly evolving and new information is regularly coming to light. The Company's customers are diverting resources to treat COVID-19 patients and deferring non-urgent and elective procedures, both of which are likely to impact customers' ability to meet their other financial obligations, including to the Company. Some customers, which include hospitals, major academic medical centers, and other related entities, have incurred significant losses during the COVID-19 pandemic due to reduced patient volume. Furthermore, the Company is also anticipating a global economic slowdown due to disruptions caused by the COVID-19 pandemic, which may result in an incremental adverse impact on revenue, net income and cash flow and may require significant additional expenditures to mitigate such impacts. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and economy as a whole. The magnitude and overall effectiveness of these actions remain uncertain. The Company’s financial results have also been affected by the COVID-19 pandemic in various ways. The COVID-19 pandemic is adversely impacting the pace at which the backlog converts to revenue in the near-term. This is primarily the result of delays in the timing of deliveries and installations in fiscal 2020 and into the first quarter of fiscal 2021 due to timing delays caused by the COVID-19 pandemic, which resulted in a decline in revenue for the same period. The Company expects that such delays in deliveries and installations will continue through fiscal 2021, which could continue to have a negative impact on revenue during such period. The Company has experienced disruptions in its sales and revenue cycle as well as increases in customer defaults, delays in payment and planned installations and service agreements as a result of the effect of the COVID-19 pandemic on the Company’s customers as well as restrictions imposed on travel. The Company also received requests from a few customers to extend payment terms or temporarily suspend service and corresponding payment obligations. While the Company has only received a small number of requests thus far, there can be no guarantee that more customers will not ask for the same if the effects of the COVID-19 pandemic deepen or worsen. As a result, the Company is carefully monitoring the pandemic and the resulting length and depth of the economic impact on our financial condition and results of operations. Given the uncertainty regarding the spread and resurgence of COVID-19 and how long the pandemic will last, the related financial impact cannot be reasonably estimated at this time, although the impacts are expected to continue and may also significantly affect the Company’s business. The Company continues to critically review its liquidity and anticipated capital requirements in light of the significant uncertainty created by the COVID-19 pandemic. Based on the Company’s cash and cash equivalents balance, available debt facilities, current business plan and revenue prospects, the Company believes that it will have sufficient cash resources and anticipated cash flows to fund its operations for at least the next 12 months. However, the Company is unable to predict with certainty the impact of the COVID-19 pandemic on its ability to maintain compliance with the debt covenants contained in the credit and security agreements related to its Revolving Credit Facility and Term Loan (as such terms are defined in Note 10 below), including financial covenants regarding the fixed charge coverage ratio, minimum net revenue, minimum consolidated cash balance and minimum consolidated domestic cash balance tests. The Company was in compliance with such covenants for the quarter ended September 30, 2020, as amended. Failure to meet the covenant requirements in the future could cause the Company to be in default and the maturity of the related debt could be accelerated and become immediately payable. This may require the Company to obtain waivers or amendments to the applicable credit and security agreement in order to maintain compliance and there can be no certainty that any such waiver or amendment will be available, or what the cost of such waiver or amendment, if obtained, would be. If the Company is unable to obtain necessary waivers or amendment and the debt under such credit facility is accelerated, the Company would be required to obtain replacement financing at prevailing market rates, which may not be favorable to the Company. There is no guarantee that the Company would be able to satisfy its obligations if any of its indebtedness is accelerated.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures at the date of the financial statements. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of the COVID-19 pandemic. Key estimates and assumptions made by the Company relate to revenue recognition, assessment of recoverability of goodwill and intangible assets, valuation of our equity method investment in the JV, valuation of inventories, share based compensation expense, convertible notes, income taxes, allowance for doubtful accounts and loss contingencies. Actual results could differ materially from those estimates.
Significant Accounting Policies	Significant Accounting Policies Other than the policy adoption discussed below under Accounting Pronouncements Recently Adopted, there have been no changes in the Company’s significant accounting policies during the three months ended September 30, 2020 compared to the significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended June 30, 2020.

Recent Accounting Pronouncements (Policies)	3 Months Ended
Recent Accounting Pronouncements (Policies)	Sep. 30, 2020
Accounting Pronouncement Recently Adopted
Accounting Pronouncements	Accounting Pronouncement Recently Adopted In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company adopted this update effective July 1, 2020 and the implementation of this update did not have a material impact on its consolidated financial position, results of operations or cash flows. In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808) to clarify revenue accounting for collaborative arrangements entered into with customers. The Company adopted this standard effective July 1, 2020. The adoption of this standard had no impact on our condensed consolidated financial statements and disclosure.
Accounting Pronouncements Not Yet Effective
Accounting Pronouncements	Accounting Pronouncements Not Yet Effective In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying Accounting for Income Taxes (“ASU 2019-12”). The amendments in ASU 2019-12 are intended to simplify various aspects related to accounting for income taxes and reduce the cost of accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for the Company beginning July 1, 2021 with early adoption permitted. The Company is evaluating the impact of adopting this standard to its consolidated financial statements and related disclosures. In January 2020, the FASB issued ASU 2020-01 Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This guidance addresses accounting for the transition into and out of the equity method and provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2020-01, which is effective for the Company in its fiscal year and interim periods beginning on July 1, 2021, to its consolidated financial statements and related disclosures. In March 2020, the FASB issued an update (“ASU 2020-04”) establishing Accounting Standards Codification (“ASC”) Topic 848, Reference Rate Reform. ASU 2020-04 contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU 2020-04 is optional and may be elected over time as reference rate reform activities occur. The Company is currently evaluating the impact of the guidance and our options related to the practical expedients.

Revenue (Tables)

3 Months Ended

Sep. 30, 2020

Summary of Contract with Customer, Asset and Liability

Changes in the contract assets and contract liabilities are as follows:

	September 30, 2020		June 30, 2020
(Dollars in thousands)	Amount		Amount
Contract Assets:
Unbilled accounts receivable – current (1)	$	12,093	$	11,739
Interest receivable – current (2)		583		493
Long-term accounts receivable (3)		3,429		3,810
Interest receivable – non-current (3)		1,286		1,342
Contract Liabilities:
Customer advances		16,712		22,571
Deferred revenue – current		81,344		83,207
Deferred revenue – non-current		24,406		24,125

(1)	Included in accounts receivable on the Company’s consolidated balance sheet

(2)	Included in prepaid expenses and other current assets on the Company’s consolidated balance sheet

(3)	Included in other assets on the Company’s consolidated balance sheet

Schedule of Remaining Performance Obligations related to Warranty

The following table represents the Company's remaining performance obligations related to long-term warranty and service as of September 30, 2020 and the estimated revenue expected to be recognized:

	Fiscal years of revenue recognition
(Dollars in thousands)	2021		2022		2023		Thereafter
Long-term warranty and service	$	29,526	$	25,530	$	13,054	$	10,550

Supplemental Financial Information (Tables)

3 Months Ended

Sep. 30, 2020

Supplemental Financial Information Disclosure [Abstract]

Schedule of financing receivables

A summary of the Company’s financing receivables is presented as follows (in thousands):

	September 30, 2020			June 30, 2020
Gross	$	13,042		$	13,019
Residual value		—			—
Unearned income		(1,805	)		(1,774	)
Allowance for credit loss		(4,380	)		(4,369	)
Total, net	$	6,857		$	6,876
Reported as:
Current	$	3,337		$	3,084
Non-current		3,520			3,792
Total, net	$	6,857		$	6,876

Schedule of inventories, net

Inventories, net consisted of the following (in thousands):

	September 30, 2020		June 30, 2020
Raw materials	$	57,168	$	48,037
Work-in-process		17,722		17,798
Finished goods		66,127		68,539
Inventories, net	$	141,017	$	134,374

Schedule of property and equipment, net

Property and equipment, net consisted of the following (in thousands):

	September 30, 2020			June 30, 2020
Furniture and fixtures	$	1,869		$	1,961
Computer and office equipment		10,486			10,896
Software		11,493			11,606
Leasehold improvements		26,082			26,206
Machinery and equipment		48,524			48,830
Construction in progress		800			623
		99,254			100,122
Less: Accumulated depreciation		(84,714	)		(84,773	)
Property and equipment, net	$	14,540		$	15,349

Schedule of accumulated other comprehensive income (loss) in the equity section

The components of accumulated other comprehensive income (loss) in the equity section of the Company’s condensed consolidated balance sheet are as follows (in thousands):

	September 30, 2020			June 30, 2020
Cumulative foreign currency translation adjustment	$	2,240		$	752
Defined benefit pension obligation		(1,231	)		(1,236	)
Accumulated other comprehensive income (loss)	$	1,009		$	(484	)

Leases (Tables)

3 Months Ended

Sep. 30, 2020

Leases [Abstract]

Schedule of Maturities of Operating Lease Liabilities

Maturities of operating lease liabilities as of September 30, 2020 are presented in the table below (in thousands):

Year Ending June 30,	Amount
2021 (remaining 9 months)	$	7,171
2022		9,311
2023		8,676
2024		5,922
2025		3,032
Thereafter		—
Total operating lease payments		34,112
Less: imputed interest		(3,136	)
Present value of operating lease liabilities	$	30,976
Weighted average remaining lease term (in years)		3.88
Weighted average discount rate		5.28	%

Goodwill and Intangible Assets (Tables)

3 Months Ended

Sep. 30, 2020

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of goodwill

Activity related to goodwill consisted of the following (in thousands):

	September 30, 2020		June 30, 2020
Balance at the beginning of the period	$	57,717	$	57,770
Currency translation		117		(53	)
Balance at the end of the period	$	57,834	$	57,717

Schedule of carrying amount of acquired intangible assets, net

The Company’s carrying amount of acquired intangible assets, net, is as follows (in thousands):

		September 30, 2020							June 30, 2020
	Useful Lives	Gross Carrying Amount		Accumulated Amortization			Net Amount		Gross Carrying Amount		Accumulated Amortization			Net Amount
	(in years)
Patent license	2 - 7	$	1,170	$	(564	)	$	606	$	1,170	$	(507	)	$	663

Schedule of estimated future amortization expense of acquired intangible assets

The estimated future amortization expense of acquired intangible assets as of September 30, 2020 is as follows (in thousands):

Year Ending June 30,	Amount
2021 (remaining 9 months)	$	171
2022		185
2023		143
2024		107
	$	606

Derivative Financial Instruments (Tables)

3 Months Ended

Sep. 30, 2020

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Schedule of gain (loss) associated with the Company's derivative financial instruments

The following table provides information about gain (loss) associated with the Company’s derivative financial instruments (in thousands):

	Three Months Ended September 30,			Three Months Ended September 30,
	2020			2019
Foreign currency exchange gain (loss) on foreign contracts	$	(910	)	$	118
Foreign currency transactions gain (loss)		404			(538	)

Fair Value Measurements (Tables)

3 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Summary of carrying values and estimated fair values of short-term and long-term debt

The following table summarizes the carrying value and estimated fair value of the Credit Facilities and the 3.75% Convertible Notes (in thousands):

	September 30, 2020				June 30, 2020
	Carrying Value		Fair Value		Carrying Value		Fair Value
3.75% Convertible Notes	$	77,374	$	73,746	$	76,398	$	65,272
Term Loan Facility		74,972		74,972		84,908		84,908
Revolving Credit Facility		27,343		27,343		28,001		28,001
Total	$	179,689	$	176,061	$	189,307	$	178,181

Debt (Tables)

3 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Schedule of carrying values of all Debt

The following table presents the carrying value of the Revolving Credit Facility, the 3.75% Convertible Notes, and the Term Loan (together, the “Notes”) (in thousands):

As of September 30, 2020	Revolving Credit Facility (1)		3.75% Convertible Notes			Term Loan Facility			Total
Carrying amount of equity conversion component	$	—	$	14,650		$	—		$	14,650
Principal amount of the Notes	$	27,343	$	85,000		$	79,948		$	192,291
Unamortized debt costs		—		(1,713	)		(785	)		(2,498	)
Unamortized debt discount		—		(5,913	)		(4,191	)		(10,104	)
Net carrying amount	$	27,343	$	77,374		$	74,972		$	179,689
Reported as:
Short-term debt									$	6,162
Long-term debt										173,527
Total debt									$	179,689

(1)	Unamortized debt costs of $0.8 million recorded in other assets on the consolidated balance sheet.

June 30, 2020	Revolving Credit Facility		3.75% Convertible Notes			Term Loan Facility			Total
Carrying amount of equity conversion component	$	—	$	14,650		$	—		$	14,650
Principal amount of the Notes	$	28,001	$	85,000		$	89,093		$	202,094
Unamortized debt costs		—		(1,922	)		(874	)		(2,796	)
Unamortized debt discount		—		(6,680	)		(3,311	)		(9,991	)
Net carrying amount	$	28,001	$	76,398		$	84,908		$	189,307
Reported as:
Short-term debt									$	—
Long-term debt										189,307
Total debt									$	189,307

Summary of interest expense on Notes and Credit Facilities

A summary of interest expense on the Notes and Credit Facilities is as follows (in thousands):

	Three Months Ended September 30,
	2020		2019
Interest expense related to contractual interest coupon	$	2,785	$	2,862
Interest expense related to amortization of debt discount		1,241		965
Interest expense related to amortization of debt issuance costs		357		329
	$	4,383	$	4,156

Share-Based Compensation (Tables)

3 Months Ended

Sep. 30, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Summary of share-based compensation expenses by functional line item

The following table presents details of share-based compensation expenses by functional line item (in thousands):

	Three Months Ended September 30,
	2020		2019
Cost of revenue	$	261	$	374
Research and development		407		372
Selling and marketing		339		(24	)
General and administrative		1,237		978
	$	2,244	$	1,700

Net Income (Loss) Per Common Share (Tables)

3 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Schedule of reconciliation of the numerator and denominator used in the calculation of basic and diluted net income (loss) per common share

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per common share follows (in thousands):

	Three Months Ended September 30,
	2020		2019
Numerator:
Net income (loss)	$	402	$	(9,356	)
Denominator:
Weighted average shares outstanding - basic		91,194		88,772
Dilutive effect of potential common shares		487		—
Weighted average shares outstanding - diluted		91,681		88,772
Basic net income (loss) per share	$	0.00	$	(0.11	)
Diluted net income (loss) per share	$	0.00	$	(0.11	)

Schedule of all potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per common share

The following table sets forth all potentially dilutive securities excluded from the computation in the table above because their effect would have been anti-dilutive (in thousands):

	As of September 30,
	2020		2019
Stock options		5,913		4,772
RSUs, PSUs and MSUs		3,092		3,083
		9,005		7,855

Segment Information (Tables)

3 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Summary of Revenue by Geographic Region

Revenues attributed to a country or region is based on the shipping addresses of the Company’s customers. The following summarizes revenue by geographic region (in thousands):

	Three Months Ended September 30,
	2020		2019
Americas	$	29,388	$	29,429
Europe, Middle East, India and Africa		28,583		31,600
Asia Pacific		15,208		14,067
Japan		12,153		14,481
Total	$	85,332	$	89,577

Schedule of Geographic Areas in Which the Company has Long Lived Tangible Assets

Information regarding geographic areas in which the Company has long-lived tangible assets is as follows (in thousands):

	September 30,		June 30,
	2020		2020
Americas	$	12,200	$	12,807
Europe, Middle East, India and Africa		367		373
Asia Pacific		885		986
Japan		1,088		1,183
Total	$	14,540	$	15,349

Revenue -Summary of Contract with Customer, Asset and Liability (Details) - USD ($)
$ in Thousands

Sep. 30, 2020

Jun. 30, 2020

Contract Assets:

Unbilled accounts receivable - current

^[1]

$ 12,093

$ 11,739

Interest receivable – current

^[2]

583

493

Long-term accounts receivable

^[3]

3,429

3,810

Interest receivable - non-current

^[3]

1,286

1,342

Contract Liabilities:

Customer advances

16,712

22,571

Deferred revenue – current

81,344

83,207

Deferred revenue – non-current

$ 24,406

$ 24,125

[1]	Included in accounts receivable on the Company’s consolidated balance sheet
[2]	Included in prepaid expenses and other current assets on the Company’s consolidated balance sheet
[3]	Included in other assets on the Company’s consolidated balance sheet

Revenue - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Recognition of deferred revenue	$ 8.8	$ 11.2
Remaining performance obligations amount	$ 984.9
Percentage of changes in operating results on entity's revenue	23.00%
Capitalized contract cost, amortization period	5 years
Capitalized costs to obtain a contract	$ 7.4		$ 7.9
Capitalized contract cost, amortization	0.7	0.5
Impairment loss	0.1	$ 0.1
Long-term Warranty and Service
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations amount	78.7
Performance Obligations Other Than Warrant
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations amount	$ 906.2

Revenue - Schedule of Remaining Performance Obligations related to Warranty (Details) - Long-term Warranty and Service $ in Thousands	Sep. 30, 2020 USD ($)
2021	$ 29,526
2022	25,530
2023	13,054
Thereafter	$ 10,550

Revenue - Additional Information (Details1) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-10-01	Sep. 30, 2020
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations recognized period	30 months
Minimum
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations percentage	21.00%
Maximum
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations percentage	28.00%

Supplemental Financial Information - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020
Financing receivables
Accounts receivable with contractual maturities of more than one year	$ 3,520		$ 3,792
Allowance for credit loss	4,380		$ 4,369
Property and equipment, net
Depreciation expense	$ 1,600	$ 1,800

Supplemental Financial Information - Summary of Financing Receivables (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020
Financing receivables
Gross	$ 13,042	$ 13,019
Unearned income	(1,805)	(1,774)
Allowance for credit loss	(4,380)	(4,369)
Total, net	6,857	6,876
Current	3,337	3,084
Non-current	$ 3,520	$ 3,792

Supplemental Financial Information - Summary of Inventories, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020
Inventory Net [Abstract]
Raw materials	$ 57,168	$ 48,037
Work-in-process	17,722	17,798
Finished goods	66,127	68,539
Inventories, net	$ 141,017	$ 134,374

Supplemental Financial Information - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020
Property and equipment, net
Property and equipment, gross	$ 99,254	$ 100,122
Less: Accumulated depreciation	(84,714)	(84,773)
Property and equipment, net	14,540	15,349
Furniture and Fixtures
Property and equipment, net
Property and equipment, gross	1,869	1,961
Computer and Office Equipment
Property and equipment, net
Property and equipment, gross	10,486	10,896
Software
Property and equipment, net
Property and equipment, gross	11,493	11,606
Leasehold Improvements
Property and equipment, net
Property and equipment, gross	26,082	26,206
Machinery and Equipment
Property and equipment, net
Property and equipment, gross	48,524	48,830
Construction in Progress
Property and equipment, net
Property and equipment, gross	$ 800	$ 623

Supplemental Financial Information - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020
Accumulated Other Comprehensive Income (Loss)
Cumulative foreign currency translation adjustment	$ 2,240	$ 752
Defined benefit pension obligation	(1,231)	(1,236)
Accumulated other comprehensive income (loss)	$ 1,009	$ (484)

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

Leases - Additional Information (Details) $ in Millions	3 Months Ended
Leases - Additional Information (Details) $ in Millions	Sep. 30, 2020 USD ($)
Leases [Abstract]
Operating lease costs	$ 2.4
Short-term operating lease costs	0.1
Cash paid for amounts included in the measurement of operating lease liabilities	2.4
Operating lease liabilities arising from obtaining operating right of-use assets	$ 0.2

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Thousands	Sep. 30, 2020 USD ($)
Leases [Abstract]
2021 (remaining 9 months)	$ 7,171
2022	9,311
2023	8,676
2024	5,922
2025	3,032
Total operating lease payments	34,112
Less: imputed interest	(3,136)
Present value of operating lease liabilities	$ 30,976
Weighted average remaining lease term (in years)	3 years 10 months 17 days
Weighted average discount rate	5.28%

Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Changes in the carrying amount of goodwill
Balance at the beginning of the period	$ 57,717	$ 57,770
Currency translation	117	(53)
Balance at the end of the period	$ 57,834	$ 57,717

Goodwill and Intangible Assets - Additional Information (Details) - USD ($)	3 Months Ended			12 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2017
Finite Lived Intangible Assets [Line Items]
Impairment of goodwill				$ 0
Amortization expense	$ 60,000.00		$ 40,000.00
Patent license
Finite Lived Intangible Assets [Line Items]
Purchase of intangible assets		$ 170,000
Useful Lives		2 years			7 years
COVID-19 Pandemic
Finite Lived Intangible Assets [Line Items]
Impairment of goodwill	$ 0

Goodwill and Intangible Assets - Schedule of Carrying Amount of Acquired Intangible Assets, Net (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Jun. 30, 2017	Jun. 30, 2020
Finite Lived Intangible Assets [Line Items]
Net Amount	$ 606			$ 663
Patent license
Finite Lived Intangible Assets [Line Items]
Useful Lives		2 years	7 years
Gross Carrying Amount	1,170			1,170
Accumulated Amortization	(564)			(507)
Net Amount	$ 606			$ 663
Patent license \| Minimum
Finite Lived Intangible Assets [Line Items]
Useful Lives	2 years
Patent license \| Maximum
Finite Lived Intangible Assets [Line Items]
Useful Lives	7 years

Goodwill and Intangible Assets - Schedule of Estimated Future Amortization Expense of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020
Estimated future amortization expense of purchased intangible assets
2021 (remaining 9 months)	$ 171
2022	185
2023	143
2024	107
Net Amount	$ 606	$ 663

Derivative Financial Instruments - Additional Information (Details) - contract	Sep. 30, 2020	Jun. 30, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Outstanding foreign currency contracts (number of contracts)	0	0

Derivative Financial Instruments - Schedule of Gain (Loss) Associated with the Company's Derivative Financial Instruments (Details) - Other expense, net - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Foreign currency exchange gain (loss) on foreign contracts	$ 404	$ (538)
Foreign contracts
Foreign currency exchange gain (loss) on foreign contracts	$ (910)	$ 118

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Aug. 31, 2017
Financial assets
Cash and cash equivalents	$ 89,955	$ 107,577
3.75% Convertible Notes
Financial assets
Interest rate (as a percent)	3.75%	3.75%	3.75%

Fair Value Measurements - Summary of Carrying Value and Estimated Fair Value of all Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020
Carrying Value
Fair value measurement
Long term debt	$ 179,689	$ 189,307
Fair Value
Fair value measurement
Long term debt	176,061	178,181
Non-recurring basis \| Carrying Value \| Level 2 \| 3.75% Convertible Notes
Fair value measurement
Long term debt	77,374	76,398
Non-recurring basis \| Fair Value \| Level 2 \| 3.75% Convertible Notes
Fair value measurement
Long term debt	73,746	65,272
Term loan \| Non-recurring basis \| Carrying Value \| Level 2
Fair value measurement
Long term debt	74,972	84,908
Term loan \| Non-recurring basis \| Fair Value \| Level 2
Fair value measurement
Long term debt	74,972	84,908
Revolving Credit Facility \| Non-recurring basis \| Carrying Value \| Level 2
Fair value measurement
Long term debt	27,343	28,001
Revolving Credit Facility \| Non-recurring basis \| Fair Value \| Level 2
Fair value measurement
Long term debt	$ 27,343	$ 28,001

Fair Value Measurements - Summary of Carrying Value and Estimated Fair Value of all Debt (Parenthetical) (Details)	Sep. 30, 2020	Jun. 30, 2020	Aug. 31, 2017
3.75% Convertible Notes
Fair value measurement
Interest rate (as a percent)	3.75%	3.75%	3.75%

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2020	Jun. 30, 2020
Financial Guarantee
Loss Contingencies [Line Items]
Bank guarantees	$ 1.3	$ 1.0

Debt - Additional Information (Details)

1 Months Ended

3 Months Ended

Jun. 14, 2017

USD ($)

Jul. 31, 2020

USD ($)

Aug. 31, 2019

USD ($)

Jul. 31, 2019

May 31, 2019

USD ($)

Apr. 30, 2019

Dec. 31, 2018

USD ($)

Dec. 31, 2017

USD ($)

Sep. 30, 2020

USD ($)

$ / shares

Sep. 30, 2019

Jun. 30, 2020

USD ($)

Aug. 31, 2017

USD ($)

Debt

Common stock value

$ 91,000

192,291,000

202,094,000

Principal prepayment of term loan

10,104,000

9,991,000

10,000,000

Term Loan Facility due December 2022

Debt

79,948,000

89,093,000

Principal prepayment of term loan

4,191,000

3,311,000

Term Loan Agreement

Debt

$ 10,000,000.0

Amendment fee

$ 500,000

Revolving Credit Facility

Debt

Initial borrowing capacity

27,343,000

^[1]

$ 28,001,000

$ 52,000,000.0

Minimum drawn balance (as a percent)

30.00%

Outstanding revolving credit facility

27,300,000

Revolving Credit Facility | Revolving Credit Agreement

Debt

Reduced borrowing capacity

$ 32,000,000.0

Term loan

Debt

Term loan | Term Loan Facility due December 2022

$ 79,900,000

Debt

Initial term loan borrowing capacity

40,000,000.0

Additional term loan borrowing capacity

$ 20,000,000.0

Loan prepayment fees for first year (percentage)

3.00%

Loan prepayment fees for second year (percentage)

2.00%

Loan prepayment fees for third year (percentage)

1.00%

Term Loan (in months)

60 months

Term of interest payable (in months)

24 months

Administrative fee payable on term loan as a percentage

0.25%

Final payment of administrative fee payable on term loan as a percentage

4.00%

Debt instrument amount withdrawn

$ 5,000,000.0

Debt instrument scheduled commitment extended termination date

Jun. 30, 2019

Debt instrument remaining unfunded commitment amount

$ 15,000,000.0

Term loan | Term Loan Facility Due May 2024

Debt

Debt instrument increased commitment amount

$ 25,000,000

$ 500,000

90-day LIBOR | Revolving Credit Facility

$ 1,600,000

$ 1,500,000

Debt

Interest rate determination basis

90-day LIBOR

Variable rate (as a percent)

4.50%

3.50%

4.50%

90-day LIBOR | Term loan | Term Loan Facility due December 2022

Debt

Interest rate determination basis

90-day LIBOR

Variable rate (as a percent)

6.75%

90-day LIBOR | Term loan | Term Loan Facility Due May 2024

Debt

Interest rate determination basis

90-day LIBOR

Variable rate (as a percent)

6.75%

5.50%

6.75%

3.75% Convertible Senior Notes due 2022

Debt

Interest rate (as a percent)

3.75%

Conversion rate, number of shares to be issued per $1000 of principal amount (in shares)

174.8252

Principal amount used for debt instrument conversion ratio

$ 1,000

Conversion price (in dollars per share) | $ / shares

$ 5.72

Aggregate principal amount of debt issued

$ 85,000,000.0

Repurchase price, as a percentage of the principal amount, in the event of a fundamental change, as defined in Indenture

100.00%

$ 85,000,000

Carrying amount of equity conversion component

$ 5,913,000

$ 6,680,000

[1]	Unamortized debt costs of $0.8 million recorded in other assets on the consolidated balance sheet.

Debt - Schedule of Carrying Values of All Debt (Details) - USD ($)
$ in Thousands

Sep. 30, 2020

Jun. 30, 2020

Debt

$ 14,650

Unamortized debt discount

192,291

202,094

Unamortized debt costs

(2,498)

(2,796)

(10,104)

(9,991)

179,689

189,307

Short-term debt

6,162

Long-term debt

173,527

189,307

Revolving Credit Facility

179,689

189,307

Debt

27,343

^[1]

28,001

27,343

^[1]

28,001

3.75% Convertible Senior Notes due 2022

27,343

^[1]

28,001

Debt

Carrying amount of equity conversion component

14,650

Unamortized debt discount

85,000

Unamortized debt costs

(1,713)

(1,922)

(5,913)

(6,680)

77,374

76,398

Term Loan Facility due December 2022

77,374

76,398

Debt

Unamortized debt discount

79,948

89,093

Unamortized debt costs

(785)

(874)

(4,191)

(3,311)

74,972

84,908

$ 74,972

$ 84,908

[1]	Unamortized debt costs of $0.8 million recorded in other assets on the consolidated balance sheet.

Debt - Schedule of Carrying Values of All Debt (Parenthetical) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020
Debt
Unamortized debt costs	$ 2,498	$ 2,796
Revolving Credit Facility \| Other Assets
Debt
Unamortized debt costs	$ 800

Debt - Summary of Interest Expense on Notes and Credit Facilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Debt Disclosure [Abstract]
Interest expense related to contractual interest coupon	$ 2,785	$ 2,862
Interest expense related to amortization of debt discount	1,241	965
Interest expense related to amortization of debt issuance costs	357	329
Total	$ 4,383	$ 4,156

Share-Based Compensation - Summary of Share-Based Compensation Expenses by Functional Line Item (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Share-based compensation expenses
Share-based compensation expense	$ 2,244	$ 1,700
Cost of revenue
Share-based compensation expenses
Share-based compensation expense	261	374
Research and development
Share-based compensation expenses
Share-based compensation expense	407	372
Selling and marketing
Share-based compensation expenses
Share-based compensation expense	339	(24)
General and administrative
Share-based compensation expenses
Share-based compensation expense	$ 1,237	$ 978

Net Income (Loss) Per Common Share - Schedule of reconciliation of the numerator and denominator used in the calculation of basic and diluted net income (loss) per common share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Numerator:
Net income (loss)	$ 402	$ (9,356)
Denominator:
Weighted average shares outstanding - basic	91,194	88,772
Dilutive effect of potential common shares	487
Weighted average shares outstanding - diluted	91,681	88,772
Basic net income (loss) per share	$ 0.00	$ (0.11)
Diluted net income (loss) per share	$ 0.00	$ (0.11)

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

Net Income (Loss) Per Common Share - Additional Information (Details) - 3.75% Convertible Senior Notes due 2022 - shares shares in Millions	3 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Aug. 31, 2017
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Interest rate (as a percent)	3.75%	3.75%	3.75%
Common stock not included in the calculation of potentially diluted shares	14.9

Net Income (Loss) Per Common Share - Schedule of all potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per common share (Details) - shares shares in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from the computation of diluted net income (loss) per share (in shares)	9,005	7,855
Stock options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from the computation of diluted net income (loss) per share (in shares)	5,913	4,772
RSUs, PSUs and MSUs
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from the computation of diluted net income (loss) per share (in shares)	3,092	3,083

Segment Information - Additional Information (Details)	3 Months Ended
Segment Information - Additional Information (Details)	Sep. 30, 2020 segment
Segment Reporting [Abstract]
Number of operating segments	1
Number of reportable segments	1

Segment Information - Summary of Revenue by Geographic Region (Details) - USD ($)
$ in Thousands

3 Months Ended

Sep. 30, 2020

Sep. 30, 2019

^[1]

$ 85,332

$ 89,577

Americas

Europe, Middle East, India and Africa

29,388

29,429

28,583

31,600

Asia Pacific

15,208

14,067

Japan

$ 12,153

$ 14,481

[1]	Includes sales to the China joint venture, an equity method investment of $4,951 and $3,817 for three months ended September 30, 2020 and 2019, respectively. See Note 14.

Segment Information - Schedule of Geographic Areas in Which the Company has Long-Lived Tangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020
Segment Information
Long lived tangible assets	$ 14,540	$ 15,349
Americas
Segment Information
Long lived tangible assets	12,200	12,807
Europe, Middle East, India and Africa
Segment Information
Long lived tangible assets	367	373
Asia Pacific
Segment Information
Long lived tangible assets	885	986
Japan
Segment Information
Long lived tangible assets	$ 1,088	$ 1,183

Joint Venture - Additional Information (Details) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Jan. 31, 2019
Schedule Of Equity Method Investments [Line Items]
Accumulated deficit	$ (481,311,000)		$ (481,713,000)
Goodwill	$ 57,834,000		57,717,000	$ 57,770,000
Impairment of goodwill			0
Accuray Asia
Schedule Of Equity Method Investments [Line Items]
Percentage of ownership interest in joint venture	49.00%				49.00%
Gain on contribution to joint venture		$ 13,000,000.0
Non cash revenue recognized from joint venture	$ 1,400,000
Joint venture associated costs	200,000
Deferred of intra-entity profit margin	1,500,000		$ 1,800,000
Previously deferred intra-entity margin from system sales	1,000,000.0
Deferral of intra entity margin from system sales	700,000
Accumulated deficit	200,000
Equity method investment	15,600,000
Proportional share of underlying equity in net assets	12,300,000
Equity method investment, intra-entity profit	1,500,000
Difference in equity method investment	3,300,000
Elimination of equity method investment intra-entity profit on sales	1,500,000
Goodwill	4,800,000
Impairment of goodwill	$ 0

Income Tax - Additional Information (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2020 USD ($) Year	Sep. 30, 2019 USD ($)
Income Taxes [Line Items]
Income tax expense	$ 344	$ 637
Number of prior years with gross receipt eligible for BEAT minimum tax \| Year	3
Gross unrecognized tax benefits	$ 17,000
Subsequent period within which no material changes in unrecognized tax benefits are expected	12 months
Minimum
Income Taxes [Line Items]
Average annual prior gross receipts threshold amount for exemption from base erosion and anti abuse tax	$ 500,000
Foreign
Income Taxes [Line Items]
Income tax expense	$ 300	$ 600

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.